[1]张召弟,郭晟,帅天姣,等.玻璃体内注射康柏西普对弥漫性糖尿病性黄斑水肿的影响[J].眼科新进展,2018,38(1):069-72.[doi:10.13389/j.cnki.rao.2018.0015]
　ZHANG Zhao-Di,GUO Sheng,SHUAI Tian-Jiao,et al.Effect of intravitreal injection of conbercept on diabetic diffuse macular edema[J].Recent Advances in Ophthalmology,2018,38(1):069-72.[doi:10.13389/j.cnki.rao.2018.0015]
点击复制

玻璃体内注射康柏西普对弥漫性糖尿病性黄斑水肿的影响/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
38卷
期数:
2018年1期
页码:
069-72
栏目:
应用研究
出版日期:
2018-01-05

文章信息/Info

Title:
Effect of intravitreal injection of conbercept on diabetic diffuse macular edema
作者:
张召弟; 郭晟; 帅天姣; 朴天华
157000　黑龙江省牡丹江市，牡丹江医学院（张召弟）；201203　上海市，上海中医药大学（郭晟）；157011　黑龙江省牡丹江市，牡丹江医学院附属红旗医院院部眼科（帅天姣，朴天华）
Author(s):
ZHANG Zhao-Di; GUO Sheng; SHUAI Tian-Jiao; PIAO Tian-Hua
Mudanjiang Medical University（ZHANG Zhao-Di），Mudanjiang 157000，Heilongjiang Province，China；Shanghai University of Traditional Chinese Medicine（GUO Sheng），Shanghai 201203，China；Mudanjiang Medical School Affiliated Red Flag Hospital Department Ophthalmology Department（SHUAI Tian-Jiao，PIAO Tian-Hua），Mudanjiang 157011，Heilongjiang Province，China
关键词:
弥漫性糖尿病性黄斑水肿; 康柏西普; 改良黄斑格栅样光凝
Keywords:
diabetic diffuse macular edema; conbercept; modified macular grid photocoagulation
分类号:
R774.5
DOI:
10.13389/j.cnki.rao.2018.0015
文献标志码:
A
摘要:
目的　探讨玻璃体内注射康柏西普对弥漫性糖尿病性黄斑水肿（diabetic macular edema，DME）的影响。方法　选取2016年7月至2017年7月牡丹江医学院红旗医院眼科收治的弥漫性DME患者51例51眼，将患者分为3组，每组各17例17眼：单纯玻璃体内注射康柏西普0.5 mg组（A组）；玻璃体内注射康柏西普0.5 mg联合改良黄斑格栅样光凝组（B组）；单纯改良黄斑格栅样光凝组（C组）。分别于治疗前及治疗后1周、1 个月、3个月和6个月对患者进行光学相干断层扫描检测黄斑中心凹厚度（central macular thickness，CMT）、眼底荧光血管造影（fundus fluorescein angiography，FFA）、最佳矫正视力（best corrected visual acuity，BCVA）、裂隙灯、眼压等检查，比较三种治疗方式的疗效和安全性。结果　三种治疗方式均能改善弥漫性DME患者BCVA、CMT、视网膜新生血管渗漏，但A组、B组疗效均优于C组（均为P＜0.05）。A组、B组患者BCVA改善情况差异无统计学意义（P＞0.05），但B组患者CMT（197.47±45.26）μm及视网膜新生血管渗漏（9.91±3.18）mm2改善情况优于A 组（205.59±47.33）μm、（13.24±4.87）mm2（P＜0.001），且无光凝术及康柏西普相关的并发症发生。结论　改良黄斑格栅样光凝术联合玻璃体内注射康柏西普能迅速减轻弥漫性DME及新生血管形成，从而提高患者视力，其疗效优于单纯改良黄斑格栅样光凝术和单纯康柏西普玻璃体内注射。
Abstract:
Objective　To investigate the effects of intravitreal injection of conbercept on diffuse macular edema (DME) of diabetes mellitus.Methods　Together 51 diabetic patients (51 eyes ) with diffuse macular edema were collected between July 2016 to July 2017，and randomly divided into three groups (n=17)：group A，in which patients received solely intravitreal injection of 0.5 mg conbercept，group B，those who was intravitreally injected with 0.5 mg of conbercept and modified macular grating photocoagulation，and group C，patients undergoing modified grid photocoagulation (GPG).Then，before treatment and 1 week，1 month，3 months and 6 months after treatment，all patients were examined by optical coherence tomography for determining central macular thickness (CMT)，followed by fundus fluorescein angiography (FFA)，the best corrected visual acuity (BCVA)，slit lamp，intraocular pressure for compare the efficacy and safety of the three procedures.Results　All the three treatments improved BCVA，CMT，retinal neovascularization (RNV) leakage in diffuse DME patients，but group A and B were better than group C (both P<0.05)，while there was no significant difference in BCVA improvement between A and B group (P>0.05)，whereas the improvement in CMT of group B patients was better than that of group A ［(197.47±45.26)μm vs.(205.59±47.33)μm］ (P<0.001)，and this was true of RNV leakage ［(9.91±3.18)mm vs.(13.24±4.87)mm］ (P<0.001)，without related complications.Conclusion　Combination of modified macular grid photocoagulation and intravitreal injection of conbercept can quickly relieve diabetic macular edema and alleviate neovascularization，thus improving the patients’ vision acuity，of which the efficacy is superior to the pure modified macular grid photocoagulation and conbercept injection.

参考文献/References:

［1］　BANDELLO F，BATTAGLIA PARODI M，TREMOLADA G，LATTANZIO R，DE BENEDETTO U，IACONO P.Steroids as part of combination treatment：The future for the management of macular edema［J］.Ophthalmologica，2010，224（Suppl 1）：41-45.
［2］　DEISSLER HL，LANG GK，LANG GE.Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells［J］.Exp Eye Res，2014，122（5）：20-31.
［3］　BOYER DS，YOON YH，RUBENS BJ，FRANCESCOB，MATURI RJ，AUGUSTIN AJ，et al.Three-year，randomized，sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema［J］.Ophthalmology，2014，121（10）：1904-1914.
［4］　LI XX，XU GZ，WANG YS，XU X，LIU XL，TANG SB，et al.Safety and efficacy of conbercept in neovascular age-related macular degeneration：results from a 12-month randomized phase 2 study：Aurora study［J］.Ophthalmology，2014，121（9）：1740-1747.
［5］　DU LP，PENG H，WU QUAN，ZHU MD，LUO DL，KE X，et al.Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept［J］.Mol Vis，2015，21（2）：185-193.
［6］　LI SH，GAO YF.Efficacy of macular focal/grid photocoagulation combined with ranibizumab for diabetic macular edema［J］.Rec Adv Ophthalmol，2015，35（6）：566-568，575.
李素华，高永峰.比较单独黄斑局灶/格栅样光凝术和联合雷珠单抗治疗糖尿病性黄斑水肿的疗效［J］.眼科新进展，2015，35（6）：566-568，575.
［7］　WEI GJ，HE DJ.532nm green grid laser photocoagulationcombined with intravitreal Avastin injectionfor diabetic retinopathy macular edema［J］.Rec Adv Ophthalmol，2014，34（8）：779-781.
魏光杰，何佃菊.532nm绿激光格栅样光凝联合球内注药治疗糖尿病视网膜病变黄斑水肿［J］.眼科新进展，2014，34（8）：779-781.
［8］　ZHANG YC，ZHAO H，ZHANG XLGAO YC，WU CY，HE JQ，et al.Changes of serum retinal，adiponectin，visfatin levels in type 2 diabetes mellitus combined with hy-pertension patients［J］.J Xinxiang Med Univ，2014，31（12）：1039-1041.
张宇晨，赵华，张晓林，高阅春，吴长燕，何继强，等.2型糖尿病合并高血压患者血清网膜素、脂联素及内脂素水平变化［J］.新乡医学院学报，2014，31（12）：1039-1041.
［9］　LI H，CAO H，WANG YS.Recent advances on laser treatment in dia-betic retinopathy［J］.Rec Adv Ophthalmol，2010，30（5）：489-492.
李红，曹虹，王雨生.激光治疗糖尿病视网膜病变的研究进展［J］.眼科新进展，2010，30（5）：489-492.
［10］　HAN J，WANG L，LIU WX，SUN HL，CAI W.Effects of compaq sipp intravitreal injection on visual acuity of diabetic retinopathy［J］.Chin Gen Pract，2015，18（5）：502-506.
韩姬，王玲，刘伟仙，孙宏亮，蔡维.康柏西普玻璃体腔注射对糖尿病视网膜病变患者视力的影响［J］.中国全科医学，2015，18（5）：502-506.
［11］　ELMAN MJ，BECK RW，BRESSLER NM，BRESSLER SB，EDWARDS AR，et al.Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema［J］.Ophthalmology，2010，117（6）：1064-1077.

相似文献/References:

[1]张娣,张玲,杨静,等.玻璃体内注射康柏西普联合手术及全视网膜光凝治疗新生血管性青光眼[J].眼科新进展,2015,35(12):1170.[doi:10.13389/j.cnki.rao.2015.0320]
　ZHANG Di,ZHANG Ling,YANG Jing,et al.Intravitreal injection of conbercept combined with operation and panretinal photocoagulation for neovascular glaucoma[J].Recent Advances in Ophthalmology,2015,35(1):1170.[doi:10.13389/j.cnki.rao.2015.0320]
[2]李娜,张杰,高荣玉,等.单次注射康柏西普治疗渗出型AMD患者RPE隆起面积与容积变化[J].眼科新进展,2016,36(2):172.[doi:10.13389/j.cnki.rao.2016.0047]
　LI Na,ZHANG Jie,GAO Rong-Yu,et al.Changes of retinal pigment epithelium uplift area and volume in exudative age-related macular degeneration after once injection of conbercept[J].Recent Advances in Ophthalmology,2016,36(1):172.[doi:10.13389/j.cnki.rao.2016.0047]
[3]王琛,李东豪,闻毅颐.玻璃体内注射康柏西普联合周边视网膜选择性光凝治疗视网膜静脉阻塞继发黄斑水肿的疗效及安全性[J].眼科新进展,2016,36(5):471.[doi:10.13389/j.cnki.rao.2016.0126]
　WANG Chen,LI Dong-Hao,WEN Yi-Yi.Intravitreal injection of conbercept combined with selective peripheral retinal photocoagulation for macular edema secondary to retinal vein occlusion[J].Recent Advances in Ophthalmology,2016,36(1):471.[doi:10.13389/j.cnki.rao.2016.0126]
[4]王玮,徐玲娟,蔡苏博,等.角膜基质及结膜下单次注射康柏西普治疗角膜新生血管的疗效及安全性[J].眼科新进展,2016,36(8):725.[doi:10.13389/j.cnki.rao.2016.0192]
　WANG Wei,XU Lin-Juan,CAI Su-Bo,et al.Efficacy and safety of one dose intrastromal and subconjunctival conbercept injection for corneal neovascularization[J].Recent Advances in Ophthalmology,2016,36(1):725.[doi:10.13389/j.cnki.rao.2016.0192]
[5]史志洁,张金嵩,吕晓贝.玻璃体内注射康柏西普联合手术治疗伴玻璃体积血的新生血管性青光眼[J].眼科新进展,2016,36(8):751.[doi:10.13389/j.cnki.rao.2016.0200]
　SHI Zhi-Jie,ZHANG Jin-Song,LV Xiao-Bei.Intravitreal injection of conbercept and surgical treatment for neovascular glaucoma combined with vitreous hemorrhage[J].Recent Advances in Ophthalmology,2016,36(1):751.[doi:10.13389/j.cnki.rao.2016.0200]
[6]翁宏武,王柯鳗,马海智,等.玻璃体内注射曲安奈德联合黄斑部格栅样光凝治疗弥漫性糖尿病性黄斑水肿[J].眼科新进展,2016,36(11):1050.[doi:10.13389/j.cnki.rao.2016.0280]
　WENG Hong-Wu,WANG Ke-Man,MA Hai-Zhi,et al.Intravitreal triamcinolone acetonide and macular grid photocoagulation for diffuse diabetic macular edema[J].Recent Advances in Ophthalmology,2016,36(1):1050.[doi:10.13389/j.cnki.rao.2016.0280]
[7]罗顺利,许泽广,梁春正.复合式小梁切除术联合康柏西普治疗新生血管性青光眼[J].眼科新进展,2016,36(11):1076.[doi:10.13389/j.cnki.rao.2016.0287]
　LUO Shun-Li,XU Ze-Guang,LIANG Chun-Zheng.Compound trabeculectomy with conbercept for neovascular glaucoma[J].Recent Advances in Ophthalmology,2016,36(1):1076.[doi:10.13389/j.cnki.rao.2016.0287]
[8]吴若欣,徐洁慧,温积全,等.玻璃体内注射康柏西普对渗出性老年性黄斑变性患者脉络膜厚度的影响[J].眼科新进展,2016,36(12):1172.[doi:10.13389/j.cnki.rao.2016.0312]
　WU Ruo-Xin,XU Jie-Hui,WEN Ji-Quan,et al.Effects of intravitreal conbercept injections on choroidal thickness in exudative age-related macular degeneration[J].Recent Advances in Ophthalmology,2016,36(1):1172.[doi:10.13389/j.cnki.rao.2016.0312]
[9]薛鹏程,游志鹏,付书华,等.23G玻璃体切割术前、术中辅助玻璃体内注射康柏西普治疗增生型糖尿病视网膜病变（PDR）的疗效分析[J].眼科新进展,2017,37(5):458.[doi:10.13389/j.cnki.rao.2017.0116]
　XUE Peng-Cheng,YOU Zhi-Peng,FU Shu-Hua,et al.Preoperative and intraoperative adjunctive intravitreal conbercept in 23G vitrectomy for proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2017,37(1):458.[doi:10.13389/j.cnki.rao.2017.0116]
[10]朱磊,田晓燕,刘涛.玻璃体内注射康柏西普治疗湿性年龄相关性黄斑变性的临床观察[J].眼科新进展,2017,37(5):473.[doi:10.13389/j.cnki.rao.2017.0120]
　ZHU Lei,TIAN Xiao-Yan,LIU Tao.Intravitreal injection of conbercept for wet age-related macular degeneration[J].Recent Advances in Ophthalmology,2017,37(1):473.[doi:10.13389/j.cnki.rao.2017.0120]

备注/Memo

备注/Memo:
牡丹江医学院研究生创新科研项目（编号：2016YJSCX-08MY）
更新日期/Last Update: 2018-01-22